Pharma

Your Article Summary

See Latest Articles

Head-to-head trial demonstrates Viramune®’s similar efficacy and more favourable effect on lipid profile compared to atazanavir/ritonavir
Boehringer Ingelheim, 09/17/09

Results from the ARTEN* trial presented at the 5th International AIDS Society conference in Cape Town, South Africa demonstrated non–inferiority regarding efficacy between Viramune and ritonavir boosted atazanavir both combined with tenofovir and emtricitabine. This head–to–head study also showed Viramune's more favourable effect on the lipid profile and now clearly confirms the combination's place as an important first line therapy for patients with HIV.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09

User Groups Prove Helpful
HealthDataManagement, 11/03/09

Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09

See All of Conferences/Meetings

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

See All of Drug Trials